Home Ingredients Chromium Polynicotinate (Niacin-Bound Chromium)
CardiovascularMetabolic Health

Chromium Polynicotinate (Niacin-Bound Chromium)

Evidence Level
Limited
2 Clinical Trials
5 Documented Benefits
2/5 Evidence Score

Chromium polynicotinate is chromium bound to niacin (vitamin B3 / nicotinic acid) — distinct from chromium picolinate (which uses picolinic acid). Marketed primarily for cholesterol management based on niacin's lipid-modifying effects (chromium contribution debated). Most cholesterol-lowering effects in chromium polynicotinate trials likely come from the niacin component, not chromium itself. Less popular than picolinate but with distinct positioning.

Studied Dose 200-400 µg elemental chromium/day; some trials use up to 1,000 µg combined with other ingredients
Active Compound Chromium polynicotinate (chromium nicotinate; ChromeMate®)

Benefits

Cholesterol Modest Effects (Likely Niacin-Driven)

Chromium polynicotinate is marketed for cholesterol lowering — but rigorous mechanistic analysis suggests the lipid effects come from the NIACIN component, not chromium. Pure niacin (vitamin B3) at pharmacological doses has well-established LDL/triglyceride lowering effects (though AIM-HIGH and HPS2-THRIVE NEGATIVE for cardiovascular outcomes when added to statins).

Supported by Trial 1, Trial 2

Chromium Bioavailability

Chromium polynicotinate has comparable absorption (~1-2%) to chromium picolinate (~1.2%) and chromium chloride (~0.4%). All forms of trivalent chromium are poorly absorbed; differences in form mostly reflect marketing rather than meaningful bioavailability advantages.

Supported by Trial 1

Glucose Metabolism (Limited)

Chromium plays a role in insulin signaling via the chromodulin/glucose tolerance factor mechanism. Supplementation in deficient populations may modestly improve glycemic markers; effect in non-deficient individuals is minimal.

Supported by Trial 1

Polynicotinate vs Other Forms (Marketing Distinction)

Some manufacturers claim polynicotinate is superior to picolinate or chloride. NIH ODS notes 'absorption of various forms of chromium is similar' — claimed superiority is largely marketing-driven.

Supported by Trial 1, Trial 2

Hypercholesterolemia Pediatric Use (Combined)

Martino 2013 examined chromium polynicotinate (1.2 mg/day) combined with policosanol or glucomannan in 120 hypercholesterolemic children. Chromium alone showed minimal effects; combination with glucomannan was modestly effective. Suggests combination products drive the response.

Supported by Trial 2

Mechanism of action

1

Trivalent Chromium and Insulin Signaling

Trivalent chromium (Cr³⁺) is component of glucose tolerance factor (GTF) and binds to chromodulin (low-molecular-weight chromium-binding substance). Chromodulin enhances insulin receptor tyrosine kinase activity at high glucose loads. Chromium DEFICIENCY impairs insulin signaling; supplementation in adequate populations has minimal effect.

2

Niacin (Vitamin B3) Lipid Effects

Niacin at pharmacological doses (1-3 g/day) reduces LDL ~15%, raises HDL ~25%, reduces triglycerides ~30%. Mechanism: inhibition of hepatic DGAT2 (triglyceride synthesis), reduced VLDL production. Note: AIM-HIGH (2011) and HPS2-THRIVE (2014) — both large rigorous trials — were NEGATIVE for adding niacin to statins for CV outcomes; deflated enthusiasm for niacin chemoprevention.

3

Polynicotinate Carrier Structure

Chromium ion bound to multiple nicotinic acid (niacin) molecules. The niacin moiety is biologically active and contributes lipid effects. Picolinate vs nicotinate distinction matters for the carrier's independent effects, less for chromium delivery itself.

4

Niacin Flushing

Pharmacological doses of niacin cause cutaneous flushing via prostaglandin D2 release. Chromium polynicotinate at typical supplemental doses (200-400 µg chromium = relatively small niacin amount) generally does not cause flushing.

Clinical trials

1
Chromium Nicotinate vs Picolinate — Comparative
PubMed

Comparative absorption and metabolic effects of chromium polynicotinate vs chromium picolinate.

Healthy adults / metabolic syndrome.

Both forms produce similar absorption; cholesterol-lowering effects favor polynicotinate, likely due to niacin component. Glucose metabolism effects similar. Picolinate has more weight management/PCOS evidence.

2
Niacin-Bound Chromium + Glucomannan in Pediatric Hypercholesterolemia — Martino 2013
PubMed

RCT (n=120, mean age 9±4) of chromium polynicotinate + glucomannan vs chromium policosanol + glucomannan vs placebo for pediatric hypercholesterolemia.

120 hypercholesterolemic children.

Combination of chromium polynicotinate + glucomannan was effective for cholesterol reduction; chromium alone was minimally effective. Suggests glucomannan drives much of the response.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated at typical doses.
Flushing if niacin component is high (uncommon at supplement doses).
GI distress at high doses.
Rare allergic dermatitis to chromium has been reported (occupational chromium exposure context).
Hexavalent vs trivalent chromium — supplements use TRIVALENT (Cr³⁺) which is essential nutrient; HEXAVALENT (Cr⁶⁺) is industrial CARCINOGEN — these are distinctly different forms; supplements are NOT the carcinogenic form.

Important Drug interactions

Insulin / hypoglycemic medications — chromium may modestly enhance insulin sensitivity; monitor blood glucose.
Beta-blockers — theoretical interaction; monitor.
Thyroid medications — chromium may reduce levothyroxine absorption; separate by 4 hours.
Antacids — may reduce chromium absorption.
Calcium carbonate — reduces chromium absorption; separate dosing.
NSAIDs — chronic NSAIDs may increase chromium absorption modestly.

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin, or vitamin B3, is a vital nutrient that supports energy production by serving as a…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Frequently asked questions about Chromium Polynicotinate (Niacin-Bound Chromium)

What is Chromium Polynicotinate (Niacin-Bound Chromium)?

Chromium polynicotinate is chromium bound to niacin (vitamin B3 / nicotinic acid) — distinct from chromium picolinate (which uses picolinic acid).

What does Chromium Polynicotinate (Niacin-Bound Chromium) do?

Trivalent chromium (Cr³⁺) is component of glucose tolerance factor (GTF) and binds to chromodulin (low-molecular-weight chromium-binding substance). Chromodulin enhances insulin receptor tyrosine kinase activity at high glucose loads. In clinical research, Chromium Polynicotinate (Niacin-Bound Chromium) has been studied for cholesterol modest effects (likely niacin-driven), chromium bioavailability, glucose metabolism (limited).

Who should take Chromium Polynicotinate (Niacin-Bound Chromium)?

Chromium Polynicotinate (Niacin-Bound Chromium) may be most relevant for people interested in cardiovascular, metabolic health. It has been clinically studied for cholesterol modest effects (likely niacin-driven), chromium bioavailability, glucose metabolism (limited). As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does Chromium Polynicotinate (Niacin-Bound Chromium) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take Chromium Polynicotinate (Niacin-Bound Chromium)?

For cardiovascular or metabolic goals, Chromium Polynicotinate (Niacin-Bound Chromium) is typically taken with meals to support absorption and reduce GI sensitivity. Effects on biomarkers (cholesterol, blood pressure, blood sugar) build over 8-12+ weeks of consistent daily use. Always check product labeling and follow personalized guidance from your healthcare provider.

Is Chromium Polynicotinate (Niacin-Bound Chromium) worth taking?

Chromium Polynicotinate (Niacin-Bound Chromium) has limited clinical evidence (Evidence Level 2/5 on NutraSmarts) — preliminary research suggests potential benefit, but more rigorous trials are needed. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. Chromium Polynicotinate (Niacin-Bound Chromium) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of Chromium Polynicotinate (Niacin-Bound Chromium)?

The clinically studied dose for Chromium Polynicotinate (Niacin-Bound Chromium) is 200-400 µg elemental chromium/day; some trials use up to 1,000 µg combined with other ingredients. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Chromium Polynicotinate (Niacin-Bound Chromium) used for?

Chromium Polynicotinate (Niacin-Bound Chromium) is studied for cholesterol modest effects (likely niacin-driven), chromium bioavailability, glucose metabolism (limited). Chromium polynicotinate is marketed for cholesterol lowering — but rigorous mechanistic analysis suggests the lipid effects come from the NIACIN component, not chromium.